Azilect News and Research

RSS
New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT

Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT

Teva Pharmaceutical Industries net sales up 25%

Teva Pharmaceutical Industries net sales up 25%

Rasagiline slows the rate of Parkinson's disease progression

Rasagiline slows the rate of Parkinson's disease progression

ADAGIO clinical trial results demonstrating AZILECT's efficacy published

ADAGIO clinical trial results demonstrating AZILECT's efficacy published

Early treatment with rasagiline (Azilect) for Parkinson's best

Early treatment with rasagiline (Azilect) for Parkinson's best

New drug for Parkinson's gets FDA approval

New drug for Parkinson's gets FDA approval

FDA approves Azilect for the treatment of Parkinson's

FDA approves Azilect for the treatment of Parkinson's